Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal for Immunotherapy of Cancer|August 20, 2025
Interleukin-12 encoded by the oncolytic virus VSV-GP enhances therapeutic antitumor efficacy by inducing CD8+ T-cell responses with a long-lived effector cell phenotypeJasmin Hatami, Krishna Das, Leonie Wolf, et al.Nature Communications|September 1, 2021
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunityKrishna Das, Elodie Belnoue, Matteo Rossi, et al.Molecular Therapy. Oncology|July 6, 2026
Oncolytic virus-delivered GSDME: Unlocking pyroptosis to improve dendritic cell function and amplify cytotoxic T cell responseSabrina Schneider, Theresa Schwaiger, Joelle Kröll, et al.NPJ Vaccines|October 16, 2024
A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2Alena Reguzova, Melanie Müller, Felix Pagallies, et al.Oncogene|May 26, 2026
An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samplesBenjamin Schoeps, Stefanie Estermann, Susanne Berchtold, et al.Pageof 2